Lobo JL - Search Results

1

Duration of Antibiotic Treatment in Community-Acquired Pneumonia: A Multicenter Randomized Clinical Trial.

Uranga A, España PP, Bilbao A, Quintana JM, Arriaga I, Intxausti M, Lobo JL, Tomás L, Camino J, Nuñez J, Capelastegui A. Uranga A, et al. Among authors: lobo jl. JAMA Intern Med. 2016 Sep 1;176(9):1257-65. doi: 10.1001/jamainternmed.2016.3633. JAMA Intern Med. 2016. PMID: 27455166 Clinical Trial.

2

[Pneumomediastinum and diffuse alveolar pain. Severe interstitial pneumopathy due to dermatomyositis].

de Dios JR, López de Goikoetxea AJ, Vesga JC, Tomás L, Zorrilla V, Lobo JL. de Dios JR, et al. Among authors: lobo jl. Reumatol Clin. 2009 Mar-Apr;5(2):76-9. doi: 10.1016/j.reuma.2008.09.002. Epub 2009 Mar 9. Reumatol Clin. 2009. PMID: 21794582 Free article. Spanish.

3

The IRYSS-COPD appropriateness study: objectives, methodology, and description of the prospective cohort.

Quintana JM, Esteban C, Barrio I, Garcia-Gutierrez S, Gonzalez N, Arostegui I, Lafuente I, Bare M, Blasco JA, Vidal S; IRYSS-COPD Group. Quintana JM, et al. BMC Health Serv Res. 2011 Nov 24;11:322. doi: 10.1186/1472-6963-11-322. BMC Health Serv Res. 2011. PMID: 22115318 Free PMC article.

4

Score to identify the severity of adult patients with influenza A (H1N1) 2009 virus infection at hospital admission.

Capelastegui A, Quintana JM, Bilbao A, España PP, Garin O, Alonso J, Astray J, Cantón R, Castilla J, Castro A, Delgado-Rodríguez M, Godoy P, Gónzález-Candelas F, Martín V, Mayoral JM, Pumarola T, Tamames S, Soldevila N, Baricot M, Domínguez A; CIBERESP Cases and Controls in Pandemic Influenza Working Group, Spain. Capelastegui A, et al. Eur J Clin Microbiol Infect Dis. 2012 Oct;31(10):2693-701. doi: 10.1007/s10096-012-1616-8. Epub 2012 Apr 24. Eur J Clin Microbiol Infect Dis. 2012. PMID: 22526871 Free PMC article.

5

Application of appropriateness criteria for hospitalization in COPD exacerbation.

Garcia-Gutierrez S, Quintana JM, Barrio I, Bare M, Fernandez N, Vidal S, Gonzalez N, Lafuente I, Arteta E, Esteban C, Pulido E; IRYSS-COPD Appropriateness Study (IRYSS-CAS) group. Garcia-Gutierrez S, et al. Intern Emerg Med. 2013 Jun;8(4):349-57. doi: 10.1007/s11739-013-0927-9. Epub 2013 Mar 19. Intern Emerg Med. 2013. PMID: 23508735

6

Predictive score for mortality in patients with COPD exacerbations attending hospital emergency departments.

Quintana JM, Esteban C, Unzurrunzaga A, Garcia-Gutierrez S, Gonzalez N, Barrio I, Arostegui I, Lafuente I, Bare M, Fernandez-de-Larrea N, Vidal S; IRYSS-COPD group. Quintana JM, et al. BMC Med. 2014 Apr 23;12:66. doi: 10.1186/1741-7015-12-66. BMC Med. 2014. PMID: 24758312 Free PMC article.

7

Subtypes of patients experiencing exacerbations of COPD and associations with outcomes.

Arostegui I, Esteban C, García-Gutierrez S, Bare M, Fernández-de-Larrea N, Briones E, Quintana JM; IRYSS-COPD Group. Arostegui I, et al. PLoS One. 2014 Jun 3;9(6):e98580. doi: 10.1371/journal.pone.0098580. eCollection 2014. PLoS One. 2014. PMID: 24892936 Free PMC article.

8

Impact of reducing the duration of antibiotic treatment on the long-term prognosis of community acquired pneumonia.

Uranga A, Artaraz A, Bilbao A, Quintana JM, Arriaga I, Intxausti M, Lobo JL, García JA, Camino J, España PP. Uranga A, et al. Among authors: lobo jl. BMC Pulm Med. 2020 Oct 7;20(1):261. doi: 10.1186/s12890-020-01293-6. BMC Pulm Med. 2020. PMID: 33028293 Free PMC article. Clinical Trial.

9

Correction to: Impact of reducing the duration of antibiotic treatment on the long-term prognosis of community acquired pneumonia.

Uranga A, Artaraz A, Bilbao A, Quintana JM, Arriaga I, Intxausti M, Lobo JL, García JA, Camino J, España PP. Uranga A, et al. Among authors: lobo jl. BMC Pulm Med. 2021 Jan 11;21(1):21. doi: 10.1186/s12890-020-01378-2. BMC Pulm Med. 2021. PMID: 33430824 Free PMC article. No abstract available.

10

Effect of a Pulmonary Embolism Diagnostic Strategy on Clinical Outcomes in Patients Hospitalized for COPD Exacerbation: A Randomized Clinical Trial.

Jiménez D, Agustí A, Tabernero E, Jara-Palomares L, Hernando A, Ruiz-Artacho P, Pérez-Peñate G, Rivas-Guerrero A, Rodríguez-Nieto MJ, Ballaz A, Agüero R, Jiménez S, Calle-Rubio M, López-Reyes R, Marcos-Rodríguez P, Barrios D, Rodríguez C, Muriel A, Bertoletti L, Couturaud F, Huisman M, Lobo JL, Yusen RD, Bikdeli B, Monreal M, Otero R; SLICE Trial Group. Jiménez D, et al. Among authors: lobo jl. JAMA. 2021 Oct 5;326(13):1277-1285. doi: 10.1001/jama.2021.14846. JAMA. 2021. PMID: 34609451 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

176 results

Search Page